CLINICAL_TRIALS
trial_result
· 2025-01-30
Clinical Trial Update: Bendamustine and Melphalan in Myeloma [Phase 2]
Summary
Phase 2 trial evaluating bendamustine plus melphalan in multiple myeloma has completed and posted results on 2025-01-30.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2025-01-30